SG
ALXN

Stonnington Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Stonnington Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,300
Closed -$422K – 300
2021
Q2 		$422K Hold
2,300
– – 0.09% 192
2021
Q1 		$396K Buy
+2,300
New +$396K 0.1% 182